15 Biggest Mid-Day Losers For Tuesday - Axon Enterprise (NASDAQ:AXON)

Axovant Sciences Ltd AXON shares dipped 72.7 percent to $6.61 after the company disclosed that Phase 3 MINDSET clinical trial did not meet its co-primary efficacy endpoints.
Genocea Biosciences Inc GNCA tumbled 66.2 percent to $1.80 after the company reported strategic shift to immuno-oncology and development of neoantigen cancer vaccines. The company also announced plans to explore strategic alternatives for GEN-003 and lower staff by 40 percent.
PTC Therapeutics, Inc. PTCT shares fell 22.8 percent to $15.06. The FDA's briefing document on PTC Therapeutics showed that 'more work would be needed to establish whether ataluren is effective.'
Kadmon Holdings Inc KDMN dropped 20.1 percent to $3.03 as the company reported mixed shelf offering.
Repligen Corporation RGEN shares fell 13.7 percent to $37.30.
Xerium Technologies, Inc. XRM shares declined 13.6 percent to $4.84.
TherapeuticsMD Inc TXMD shares dropped 10.9 percent to $5.40. TherapeuticsMD priced its 12.4 million share offering at $5.65 per share.
IHS Markit Ltd INFO fell 7.8 percent to $44.53. IHS Markit posted Q3 adjusted earnings of $0.57 per share on revenue of $904.7 million. The company also reported the acquisition of automotiveMastermind Inc. for $392 million.
QEP Resources Inc QEP shares slipped 7.7 percent to $8.20 after the company reported the closing of Pinedale asset sale and lowered its FY17 production outlook.
World Fuel Services Corp INT declined 7.1 percent to $34.17. Bank of America downgraded World Fuel Services from Neutral to Underperform.
Shake Shack Inc SHAK fell 6 percent to $31.59. Wedbush downgraded Shake Shack from Outperform to Neutral.
Aradigm Corporation ARDM shares dropped 5.7 percent to $3.17 after climbing 32.81 percent on Monday.
Sabra Health Care REIT Inc SBRA declined 5.4 percent to $21.13. Sabra Health Care REIT priced an underwritten public offering of 16,000,000 shares at $21.00 per share.
ProQR Therapeutics NV PRQR fell 5.1 percent to $6.12 after the company disclosed top-line data from Phase 1b study of QR-010.
Darden Restaurants, Inc. DRI shares slipped 4.5 percent to $79.37. Darden posted in-line quarterly earnings.

Market News and Data brought to you by Benzinga APIs